Literature DB >> 18157909

Neuropathological basis of magnetic resonance images in aging and dementia.

William J Jagust1, Ling Zheng, Danielle J Harvey, Wendy J Mack, Harry V Vinters, Michael W Weiner, William G Ellis, Chris Zarow, Dan Mungas, Bruce R Reed, Joel H Kramer, Norbert Schuff, Charles DeCarli, Helena C Chui.   

Abstract

OBJECTIVE: Magnetic resonance (MR) imaging is used widely for assessment of patients with cognitive impairment, but the pathological correlates are unclear, especially when multiple pathologies are present.
METHODS: This report includes 93 subjects from a longitudinally followed cohort recruited for the study of Alzheimer's disease (AD) and subcortical cerebrovascular disease (CVD). MR images were analyzed to quantify cortical gray matter volume, hippocampal volume, white matter hyperintensities, and lacunes. Neuropathological examination quantified CVD parenchymal pathology, AD pathology (defined as Consortium to Establish a Registry for Alzheimer's Disease scores and Braak and Braak stage), and hippocampal sclerosis. Subjects were pathologically classified as 12 healthy control subjects, 46 AD, 14 CVD, 9 mixed AD/CVD, and 12 cognitively impaired patients without significant AD/CVD pathology. Multivariate models tested associations between magnetic resonance and pathological findings across the entire sample.
RESULTS: Pathological correlates of cortical gray matter volume were AD, subcortical vascular pathology, and arteriosclerosis. Hippocampal volume was related to AD pathology and hippocampal sclerosis, and the effects of hippocampal sclerosis were greater for subjects with low levels of AD pathology. White matter hyperintensities were related to age and to white matter pathology. Number of MRI lacunes was related to subcortical vascular pathology.
INTERPRETATION: In this clinical setting, the presence of lacunes and white matter changes provide a good signal for vascular disease. The neuropathological basis of MR defined cerebral cortical and hippocampal atrophy in aging and dementia is complex, with several pathological processes converging on similar brain structures that mediate cognitive decline.

Entities:  

Mesh:

Year:  2008        PMID: 18157909      PMCID: PMC2624571          DOI: 10.1002/ana.21296

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

1.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study.

Authors:  J C de Groot; F E de Leeuw; M Oudkerk; J van Gijn; A Hofman; J Jolles; M M Breteler
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

2.  Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.

Authors:  Elisabeth C W van Straaten; Franz Fazekas; Egill Rostrup; Philip Scheltens; Reinhold Schmidt; Leonardo Pantoni; Domenico Inzitari; Gunhild Waldemar; Timo Erkinjuntti; Riita Mäntylä; Lars-Olof Wahlund; Frederik Barkhof
Journal:  Stroke       Date:  2006-01-26       Impact factor: 7.914

3.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology.

Authors:  Helena C Chui; Chris Zarow; Wendy J Mack; William G Ellis; Ling Zheng; William J Jagust; Dan Mungas; Bruce R Reed; Joel H Kramer; Charles C Decarli; Michael W Weiner; Harry V Vinters
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

4.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors: 
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

5.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

Authors:  Bruce R Reed; Dan M Mungas; Joel H Kramer; William Ellis; Harry V Vinters; Chris Zarow; William J Jagust; Helena C Chui
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

7.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

Review 8.  Neuropathologic substrates of ischemic vascular dementia.

Authors:  H V Vinters; W G Ellis; C Zarow; B W Zaias; W J Jagust; W J Mack; H C Chui
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

9.  Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease.

Authors:  T A Ala; G O Beh; W H Frey
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

10.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease.

Authors:  R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

View more
  135 in total

1.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

2.  White matter hyperintensity penumbra.

Authors:  Pauline Maillard; Evan Fletcher; Danielle Harvey; Owen Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

3.  Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Authors:  Owen Carmichael; Jing Xie; Evan Fletcher; Baljeet Singh; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

Review 4.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

5.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

6.  Magnetic resonance imaging volume of the angular gyri predicts financial skill deficits in people with amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Christopher C Stewart; Luke E Stoeckel; Ozioma C Okonkwo; Jan A den Hollander; Roy C Martin; Katherine Belue; Jacquelynn N Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

7.  Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.

Authors:  Anna Rieckmann; Trey Hedden; Alayna P Younger; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Hum Brain Mapp       Date:  2015-11-06       Impact factor: 5.038

8.  Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults.

Authors:  Ling Zheng; Wendy J Mack; Helena C Chui; Lara Heflin; Dan Mungas; Bruce Reed; Charles DeCarli; Michael W Weiner; Joel H Kramer
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

9.  Lower hippocampal volume predicts decrements in lane control among drivers with amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Ozioma C Okonkwo; Christopher C Stewart; Luke E Stoeckel; Jan A den Hollander; Jennifer M Elgin; Lindy E Harrell; John C Brockington; David G Clark; Karlene K Ball; Cynthia Owsley; Daniel C Marson; Virginia G Wadley
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-12       Impact factor: 2.680

10.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.